1 - 25 of 350
Number of results to display per page
TitleCreatorDate
1 Cases of Ischemic Optic Neuropathy Associated With Phosphodiesterase-5 Inhibitor Use Reported to the Food and Drug Administration Adverse Event Reporting SystemHoward D. Pomeranz, MD, PhD2016-06
2 Research Registries: A Tool to Advance Understanding of Rare Neuro-Ophthalmic DiseasesKimberly D. Blankshain, BS; Heather E. Moss, MD, PhD2016-09
3 Association Between Phosphodiesterase-5 Inhibitors and Nonarteritic Anterior Ischemic Optic NeuropathyNawaaz A Nathoo; Mahyar Etminan; Frederick S Mikelberg
4 Diagnostic Features of Retinal Nerve Fiber Layer Rotation in Skew Deviation Using Optical Coherence TomographyChen, John J; Kardon, Randy H; Longmuir, Reid A
5 Dominant Optic Atrophy: How to Determine the Pathogenicity of Novel Variants?Jason A. Zehden; Subahari Raviskanthan; Peter W. Mortensen; Marc Ferré; Pascal Reynier; Dan Milea; Andrew G. Lee2022-06
6 Validity of International Classification of Diseases Codes for Identifying Neuro-Ophthalmic Disease in Large Data Sets: A Systematic ReviewAli G. Hamedani, MD, MHS; Lindsey B. De Lott, MD, MS; Tatiana Deveney, MD; Heather E. Moss, MD, PhD2020-12
7 Increased Incidence of Pseudotumor Cerebri Syndrome Among Users of Tetracycline AntibioticsSamuel F. Passi; Ryan Butcher; Daniel R. Orme; Judith E. A. Warner; Gregory J. Stoddard; Alison V. Crum; Ramkiran Gouripeddi; Brian H. Kirk; Kathleen B. Digre; Bradley J. Katz2022-09
8 Literature CommentaryMark L. Moster, MD; Marc J. Dinkin, MD; Deborah I. Friedman, MD, MPH2022-12
9 Optic Nerve Abnormalities in Morning Glory Disc Anomaly: An MRI StudyDiem-Trang Nguyen; Nathalie Boddaert; Dominique Bremond-Gignac; Matthieu P. Robert2022-06
10 Baseline Retinal Nerve Fiber Layer Thickness and Macular Volume Quantified by OCT in the North American Phase 3 Fingolimod Trial for Relapsing-Remitting Multiple SclerosisWinges, Kimberly M; Werner, John S; Harvey, Danielle J; Cello, Kimberly E; Durbin, Mary K; Balcer, Laura J; Calabresi, Peter A; Keltner, John L
11 Deep Learning and Transfer Learning for Optic Disc Laterality Detection: Implications for Machine Learning in Neuro-OphthalmologyT. Y. Alvin Liu; Daniel S. W. Ting; Paul H. Yi; Jinchi Wei; Hongxi Zhu; Prem S. Subramanian; Taibo Li; Ferdinand K. Hui; Gregory D. Hager; Neil R. Miller2020-06
12 Stroke Rate, Subtype, and Cardiovascular Risk Factors in Nonarteritic Anterior Ischemic Optic Neuropathy: A Population-Based StudyRobert C. Foster; M. Tariq Bhatti; Olivia M. Crum; Elizabeth R. Lesser; David O. Hodge; James P. Klaas; John J. Chen2020-09
13 Multifocal electroretinographic abnormalities in ethambutol-induced visual loss.Liu, Yao; Dinkin, Marc J; Loewenstein, John I; Joseph F. Rizzo III, M.D.; Cestari, Dean M
14 Table of Contents
15 Asymmetric Papilledema in Idiopathic Intracranial HypertensionSamuel Bidot; Beau B Bruce; Amit M Saindane; Nancy J Newman; Valrie Biousse
16 Avoiding Clinical Misinterpretation and Artifacts of Optical Coherence Tomography Analysis of the Optic Nerve, Retinal Nerve Fiber Layer, and Ganglion Cell LayerJohn J. Chen, MD, PhD; Randy H. Kardon, MD, PhD2016-12
17 Optic Neuritis Associated With Tumor Necrosis Factor-Alpha Inhibitor CertolizumabAriel Chen, MD; Neil R. Miller, MD; Thomas M. Bosley, MD2021-12
18 Table of Contents
19 Table of Contents
20 Table of Contents
21 Table of Contents
22 Antibody Development in Patients Treated Long-Term With OnabotulinumtoxinA for Benign Essential Blepharospasm and Hemifacial SpasmCraig N. Czyz, DO; John A. Burns, MD; Reece E. Bergstrom, DO2021-12
23 Food and Drug Administration Adverse Event Reports of Retinal Vascular Occlusions Associated With Phosphodiesterase Type 5 Inhibitor UseAlbert S. Li, MD; Howard D. Pomeranz, MD, PhD2016-12
24 Best Catch from NANOSNETCornblath, WT; Calvert, PC
25 Literature Commentary
1 - 25 of 350